Pneumococcal Infection
📧 Sign up to get email alerts when something new happens for Pneumococcal Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In China [Phase 3]
A Phase 3 trial evaluating the 13-valent pneumococcal conjugate vaccine (13vPnC) in healthy infants in China has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Clinical Trial of PCV24 in Adults Aged ≥18 Years [Phase 1, Phase 2]
This document reports the completion of Phase 1/2 clinical trials of the PCV24 pneumococcal vaccine in adults aged 18 years and older.
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013) [Phase 3]
Phase 3 trial of the V116 vaccine for pneumococcal infection in children and teenagers has been completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants [Phase 2]
GlaxoSmithKline completed a Phase 2 trial evaluating the safety, tolerability, and immune response of the AFX3772 vaccine in healthy infants…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV
Pfizer-sponsored clinical trial evaluating the effects of a pneumococcal vaccine in people with HIV has completed and posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: A Clinical Trial to Observe the Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Target Population
A completed clinical trial assessing the safety of the 23-valent pneumococcal polysaccharide vaccine in the target population. Sponsor: Sino…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease (V116-008) [Phase 3]
Phase 3 trial update reporting safety and immunogenicity results for the V116 pneumococcal vaccine in adults at increased risk for pneumococ…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants [Phase 4]
Phase 4 trial in Kenyan infants assessing whether fractional dosing of pneumococcal conjugate vaccines preserves immunogenicity and reduces …
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Phase I Clinical Trial of PCV24 in People Aged 18 Years and Older [Phase 1]
Phase I clinical trial of PCV24 in adults aged 18 and older has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years. [Phase 2]
Phase 2 clinical trial update for a pneumococcal conjugate vaccine tested in adults aged 50 to 84; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-06-10Clinical Trial Update: Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults (V116-003, STRIDE-3) [Phase 3]
Phase 3 trial evaluating safety and immunogenicity of V116 in pneumococcal vaccine-naïve adults has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2024-02-13Clinical Trial Update: Safety, Tolerability, and Immunogenicity of V110 or V114 Co-administered With a Booster Dose of mRNA-1273 in Healthy Adults (V110-911) [Phase 3]
Phase 3 study results assess safety, tolerability, and immunogenicity of co-administering V110 or V114 with a booster dose of mRNA-1273 in h…
-
CLINICAL_TRIALS trial_result · 2023-07-07Clinical Trial Update: Safety, Tolerability, and Immunogenicity of a Polyvalent Pneumococcal Conjugate Vaccine (V116) in Japanese Adults (V116-002) [Phase 1]
Phase 1 trial update on safety, tolerability, and immunogenicity of the polyvalent pneumococcal conjugate vaccine V116 in Japanese adults; r…
-
CLINICAL_TRIALS trial_result · 2022-09-14Clinical Trial Update: Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam [Phase 2, Phase 3]
A completed Phase 2/Phase 3 clinical trial evaluating pneumococcal vaccine schedules in Ho Chi Minh City, Vietnam.
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents [Phase 4]
Phase 4 clinical trial evaluating pneumococcal vaccination in multiple myeloma patients receiving novel therapies has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Immunogenicity of PPV23 Vaccine Revaccinated in 60-70 Years Old [Phase 4]
A Phase 4 trial evaluating safety and immunogenicity of revaccination with PPV23 in adults aged 60-70 years has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Open Randomized Trial Evaluating Four Anti-pneumococcal Vaccine Strategies With Fractionated Doses of Non Conjugate Polysaccharide Vaccine to Prevent Hyporesponse in Healthy Volunteers [Phase 2]
Phase 2 randomized trial evaluating four anti-pneumococcal vaccine strategies using fractionated doses of non-conjugate polysaccharide vacci…
-
CLINICAL_TRIALS trial_result · 2020-09-30Clinical Trial Update: Study To Describe The Safety, Tolerability, And Immunogenicity Of 13- Valent Pneumococcal Conjugate Vaccine Formulated In Multidose Vials When Given With Routine Pediatric Vaccines In Healthy Infants In India [Phase 4]
Phase 4 trial assessing safety, tolerability, and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy Indian infants whe…
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Safety and Immunogenicity of Anti-Pneumococcal Vaccines in HIV-Infected Pregnant Women [Phase 2]
Phase 2 trial updating safety and immunogenicity of anti-pneumococcal vaccines in HIV-infected pregnant women has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: A Study to Evaluate the Safety and Immunogenecity of LBVE(Multivalent Pneumococcal Conjugate Vaccine) in Healthy Infants [Phase 2]
A Phase 2 study assessing safety and immunogenicity of LBVE Multivalent Pneumococcal Conjugate Vaccine in healthy infants has completed.
-
CLINICAL_TRIALS trial_result · 2019-03-22Clinical Trial Update: Study to Evaluate the Immune Response of United Kingdom (UK) Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life [Phase 4]
A Phase 4 clinical trial evaluated immune responses and antibody persistence in UK infants receiving multiple vaccines, including boosters i…
-
CLINICAL_TRIALS trial_result · 2018-06-13Clinical Trial Update: A Study to Evaluate the Safety and Immunogeneicity of Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults [Phase 1]
LG Chem is conducting a Phase 1 clinical trial to evaluate the safety and immunogenicity of a multivalent pneumococcal conjugate vaccine in …
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine [Phase 4]
Phase 4 trial assessed immunogenicity and safety of a tetanus-diphtheria vaccine given with a 13-valent pneumococcal conjugate vaccine; the …
-
CLINICAL_TRIALS trial_result · 2017-12-14Clinical Trial Update: Vaccination Course in Primed Children and Age-matched Unprimed Children With Pneumococcal Vaccine GSK1024850A [Phase 3]
Phase 3 trial evaluating a pneumococcal vaccine (GSK1024850A) in primed and age-matched unprimed children; study completed with results post…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Protection Against Pneumococcal Infection in Children With T1DM [Phase 4]
Phase 4 trial update indicating completion of a study on protection against pneumococcal infection in children with Type 1 Diabetes Mellitus…